Lista de obras - Ana M Muñoz - Dominio Público Uruguay

Aging-related Increase in Rho Kinase Activity in the Nigral Region Is Counteracted by Physical Exercise.

artículo científico publicado en 2015

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β.

artículo científico publicado en 2014

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

artículo científico publicado en 2006

Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

artículo científico publicado en 2013

BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats

artículo científico publicado en 2017

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

artículo científico publicado en 2008

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia

artículo científico publicado en 2008

Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.

artículo científico publicado en 2016

Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: Interaction between the serotonergic, glutamatergic, and dopaminergic systems

scientific article published on 01 March 2000

GABAA receptor subunit expression in intrastriatal ventral mesencephalic transplants

artículo científico publicado en 2000

Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage

artículo científico publicado en 2005

Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.

artículo científico publicado en 2015

Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses

artículo científico publicado en 2003

Hypothyroidism is associated with increased myostatin expression in rats.

artículo científico publicado en 2008

Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration

artículo científico publicado en 2008

Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats

artículo científico publicado en 2003

Involvement of the serotonin system in L-dopa-induced dyskinesias

scientific article published on 24 June 2008

Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death

artículo científico publicado en 2010

Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease

artículo científico publicado en 2001

Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

artículo científico publicado en 2007

Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum

artículo científico publicado en 2001

Morphology and neurochemistry of two striatal neuronal subtypes expressing the GABAA receptor α3-subunit in the rat

artículo científico publicado en 2000

Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease

artículo científico publicado en 2010

Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia

artículo científico publicado en 2021

Physical Exercise Improves Aging-Related Changes in Angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the Substantia Nigra

artículo científico publicado en 2018

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.

artículo científico publicado en 2006

Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease

artículo científico publicado en 2010

Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors

scientific journal article

Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.

artículo científico publicado en 2009

Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias

artículo científico publicado en 2008

Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

artículo científico publicado en 2014

Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.

artículo científico publicado en 2004

Lista de obras de Ana M Muñoz

Aging-related Increase in Rho Kinase Activity in the Nigral Region Is Counteracted by Physical Exercise.

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β.

Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia

Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.

Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: Interaction between the serotonergic, glutamatergic, and dopaminergic systems

GABAA receptor subunit expression in intrastriatal ventral mesencephalic transplants

Glial overexpression of heme oxygenase-1: a histochemical marker for early stages of striatal damage

Hints on the Lateralization of Dopamine Binding to D1 Receptors in Rat Striatum.

Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses

Hypothyroidism is associated with increased myostatin expression in rats.

Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration

Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats

Involvement of the serotonin system in L-dopa-induced dyskinesias

Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death

Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease

Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum

Morphology and neurochemistry of two striatal neuronal subtypes expressing the GABAA receptor α3-subunit in the rat

Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease

Novel Interactions Involving the Mas Receptor Show Potential of the Renin-Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia

Physical Exercise Improves Aging-Related Changes in Angiotensin, IGF-1, SIRT1, SIRT3, and VEGF in the Substantia Nigra

Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.

Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease

Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors

Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model.

Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias

Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.